US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Prescription Drugs: market research reports

RSS Feeds

Prescription Drugs market research reports and industry analysis

  2    4  5  6  7  8  9  10  
Pharmaceuticals and Healthcare Report - Iraq - Q3 2014
7/23/2014 | published by: Business Monitor International
... expansions in 2014, and the Ministry of Health recently awarded 18 health project contractsworth USD276mn. In addition, new restrictions aim to end the chaos in which materials have entered thecountry in previous years, targeting control ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Kuwait - Q3 2014
7/23/2014 | published by: Business Monitor International
... is likely tohave a significant impact on margins in the sector, implementation remains slow. Concern over fakegeneric drugs presents opportunities for the segment in the country, and has spurred partnershipagreements with local distributors in the ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Portugal - Q3 2014
7/23/2014 | published by: Business Monitor International
... to growth in 2015, while pharmaceuticals will not return to growth until 2019. This isbecause while Portugal exited its bailout programme in May 2014 without the need for a new financialpackage, government austerity measures are ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Qatar - Q3 2014
7/23/2014 | published by: Business Monitor International
... by the membercountries of the Gulf Co-operation Council (GCC). The unified regional pharmaceutical pricingpolicy among GCC member states will reduce medicine prices in Qatar and improve its national drugaccessibility, if implemented properly. Although the drug ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - South Africa - Q3 2014
7/23/2014 | published by: Business Monitor International
... and poised for high single-digitgrowth over the next decade. Headline Expenditure Projections Pharmaceuticals: ZAR34.01bn (USD3.52bn) in 2013 to ZAR37.53bn (USD3.51bn) in 2014; +10.3% inlocal currency terms and -0.5% in US dollar terms. Forecast broadly in ...  |  read more...
USD 1,295
Physician Views: Is the HER2-positive breast cancer extended adjuvant opportunity big enough to support neratinib's blockbuster forecasts?
7/28/2014 | published by: FirstWord
... Data indicates that treatment with neratinib for 12 months following standard 12-month therapy with Herceptin increases disease-free survival by 33 percent versus placebo. Significantly, there appear to be no other products in development for usage ...  |  read more...
USD 645
Pharmaceuticals and Healthcare Report Q3 2014 - Greece
7/16/2014 | published by: Business Monitor International
... will continue to target the pharmaceutical and healthcare industry to reduce public spending.We highlight, however, that the generic drug sector and private healthcare industry will present somegrowth opportunities in the country. Headline Expenditure Projections Pharmaceuticals: ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Lithuania
7/16/2014 | published by: Business Monitor International
... The upcoming switch to theeuro promises to boost purchasing power and stabilise the pharmaceutical market, albeit at the cost ofincreasing healthcare expenditure. Ceding control of monetary policy to Brussels leaves Lithuania withlittle leeway to increase ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Serbia
7/16/2014 | published by: Business Monitor International
... reduce itsdebt burden. However, pharmaceutical spending is also a target for cuts. Local drug makers are set to feelthe worst of these new measures as they cannot compete on cost compared to larger players in ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Slovakia
7/16/2014 | published by: Business Monitor International
... agencyTASR. The government added that after adding contributions from the state budget, the total funds that havebeen allocated for developing healthcare infrastructure will be EUR300mn (USD417.3mn). The governmentplans to allocate these funds to projects in ...  |  read more...
USD 1,295
Global Rheumatoid Arthritis Drugs Market : 2014-2018
7/14/2014 | published by: TechNavio - Infiniti Research Ltd.
... AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Janssen Pharmaceuticals Inc., Pfizer Inc. , AB Science SA, Astellas Pharma Inc., AstraZeneca plc, Biogen Idec Inc., Boehringer Ingelheim GmbH, Celgene Corp., Daiichi Sankyo ...  |  read more...
USD 2,500
Databook Q1 2014: China Digital Advertising Spend - Pharmaceutical & Healthcare Industry
6/26/2014 | published by: Socintel360
... total online advertising. During 2009-2013, online advertising in this industry has increased at a CAGR of 31.9%. This growth is expected to continue in 2014 with brands expected to spend US$637 million, representing an increase ...  |  read more...
USD 225
Databook Q1 2014: China Social Media Advertising Spend - Pharmaceutical & Healthcare Industry
6/26/2014 | published by: Socintel360
... 3.1% of total social media advertising. During 2009-2013, social media advertising in this industry has increased at a CAGR of 42.6%. This growth is expected to continue in 2014 with brands expected to spend US$56 ...  |  read more...
USD 400
Human Growth Hormone Drugs
6/1/2014 | published by: Global Industry Analysts
... analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market ...  |  read more...
USD 4,950
Databook Q1 2014: Brazil Social Media Advertising Spend - Pharmaceutical & Healthcare Industry
6/26/2014 | published by: Socintel360
... 3.0% of total social media advertising. During 2009-2013, social media advertising in this industry has increased at a CAGR of 98.5%. This growth is expected to continue in 2014 with brands expected to spend US$14 ...  |  read more...
USD 400
Databook Q1 2014: Russia Social Media Advertising Spend - Pharmaceutical & Healthcare Industry
6/26/2014 | published by: Socintel360
... 1.8% of total social media advertising. During 2009-2013, social media advertising in this industry has increased at a CAGR of 54.0%. This growth is expected to continue in 2014 with brands expected to spend US$09 ...  |  read more...
USD 400
Databook Q1 2014: UK Digital Advertising Spend - Pharmaceutical & Healthcare Industry
6/26/2014 | published by: Socintel360
... of total online advertising. During 2009-2013, online advertising in this industry has increased at a CAGR of 11.1%. This growth is expected to continue in 2014 with brands expected to spend US$338 million, representing an ...  |  read more...
USD 225
Databook Q1 2014: India Digital Advertising Spend - Pharmaceutical & Healthcare Industry
6/26/2014 | published by: Socintel360
... total online advertising. During 2009-2013, online advertising in this industry has increased at a CAGR of 48.9%. This growth is expected to continue in 2014 with brands expected to spend US$26 million, representing an increase ...  |  read more...
USD 225
Databook Q1 2014: Brazil Digital Advertising Spend - Pharmaceutical & Healthcare Industry
6/26/2014 | published by: Socintel360
... total online advertising. During 2009-2013, online advertising in this industry has increased at a CAGR of 28.5%. This growth is expected to continue in 2014 with brands expected to spend US$105 million, representing an increase ...  |  read more...
USD 225
Databook Q1 2014: Russia Digital Advertising Spend - Pharmaceutical & Healthcare Industry
6/26/2014 | published by: Socintel360
... total online advertising. During 2009-2013, online advertising in this industry has increased at a CAGR of 43.6%. This growth is expected to continue in 2014 with brands expected to spend US$63 million, representing an increase ...  |  read more...
USD 225
Pharmaceuticals: Romania Pharmaceutical Report - Q1, 2014
6/2/2014 | published by: Intellinews
... terms for the third quarter in a row in Q1/2014. In volume terms, the market shrank by 4.2% y/y over the quarter, steepening from the 3.6% y/y decline in Q4/2013 and compared to the slight ...  |  read more...
USD 475
Pharmaceuticals and Healthcare : Belgium Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
... highly developed pharmaceutical manufacturing industryis increasingly threatened by cheaper suppliers from Eastern Europe and Asia. Even though percapita spending on pharmaceuticals is relatively high, it is subjected to continual downward pressure, whichtranslates into growth opportunities ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Brazil Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
... improving regulatory regimeand significant private healthcare growth mean that the market presents significant revenue-generatingopportunities for drugmakers and healthcare service providers. However, multinationals will continue toface increasing drug pricing pressure and domestic competition. Headline Expenditure Projections ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Estonia Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
... in pharmaceutical spending in Estonia as theEstonian government's policy of fiscal restraint continues. Fiscal tightening has lead to pressure on theEstonian Health Insurance Fund to rein in pharmaceutical expenditure through pricing limits, genericprescribing and reference ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : France Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
... deficit reduction target of 3.0% of GDP by 2015 - affectingexpenditure on pharmaceuticals and healthcare as a part of the government's fiscal consolidation plans. However, the new government of Manuel Valls has indicated it may ...  |  read more...
USD 1,295
  2    4  5  6  7  8  9  10